Describes some basic properties of the real options approach used in research and development (R&D) project evaluation. Concern over the applicability of the approach to a wide range of R&D related problems; Use of the Geske model of option evaluation; Use of option pricing theory to real value options; Use of the real option valuation in pharmaceutical research.